Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. Lancet Microbe 2021; published online April 20. https://doi.org/10.1016/S2666-5247(21)00069-0—In this Comment, the relative risk reduction for the Gamaleya vaccine should have been 91%, and the numbers needed to vaccinate should have been 81 for the Moderna–NIH, 108 for the Gamaleya, and 119 for the Pfizer–BioNTech vaccines. These corrections have been made to as of June 11, 2021.
. 2021 Jun 11;2(7):e288. doi: 10.1016/S2666-5247(21)00152-X
Correction to Lancet Microbe 2021; published online April 20. https://doi.org/10.1016/S2666-5247(21)00069-0
Issue date 2021 Jul.
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9247853 PMID: 35544162
This corrects the article "COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room" on page e279.